Evidence map›Paper›PMID 39335476›Full record

ArticleBiomedicines2024

The Role of Body Mass Index (BMI) in Differentiated Thyroid Cancer: A Potential Prognostic Factor?

Chiara Mele, Lucrezia De Marchi, Giulia Marsan, Marco Zavattaro, Maria Grazia Mauri, Paolo Aluffi Valletti, Gianluca Aimaretti, Paolo Marzullo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chiara MeleDepartment of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0003-2880-9373
Lucrezia De MarchiDepartment of Endocrinology, UZ Brussel, Laarbeeklaan, 1090 Brussels, Belgium.
Giulia MarsanDepartment of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.
Marco ZavattaroDivision of Endocrinology, University Hospital "Maggiore della Carità", 28100 Novara, Italy.
Maria Grazia MauriDivision of Endocrinology, University Hospital "Maggiore della Carità", 28100 Novara, Italy.
Paolo Aluffi VallettiENT Division, University of Piemonte Orientale, 28100 Novara, Italy.
Gianluca AimarettiDepartment of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0002-6186-0106
Paolo MarzulloDepartment of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0003-3215-5747

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity has been recognized as a potential risk factor for the carcinogenesis of differentiated thyroid cancer (DTC). The aim of this observational study was to investigate the prognostic role of BMI in influencing DTC histopathological aggressiveness and the risk of tumor relapse. We enrolled 257 patients with DTC, consecutively admitted to our Institution between January 2016 and December 2023. The following variables were collected: demographic, anthropometric and clinical parameters, risk factors for DTC, surgical and radioiodine therapy, histopathological features of DTC, and biochemical markers of disease. Tumor recurrence was assessed during short-, medium- and long-term follow-up. According to BMI tertiles (e.g; I: BMI < 23.3 kg/m

Indexed as

body mass indexobesityoutcomethyroid cancertumor aggressiveness

Identifiers

PMID39335476
PMCPMC11428425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.